P2D Biosciencep2Dis A Specialty Pharmaceutical Company Focused On Developing Innovative Drugs That Fulfill Unmet Medical Needs In The Treatment Of Central Nervous Systemcnsand Pulmonary Disorders Including Attention Deficit Hyperactivity Disorderadhd Obesityanxietydepressionalzheimer S Diseasetraumatic Brain Injury And Chronic Obstructive Pulmonary Diseasecopd At P2Dour Experienced Drug Development Team Utilizes Our In Depth Understanding Of The Clinical Treatment Of Cns Disorders And Neurodegenerative Diseases To Efficiently Build A Product Portfolio Of Therapeutics With An Improved Likelihood For Clinical Successour Goal Is To Advance A Product Candidate Through Preclinical Development And Clinical Proof Of Concept By Producing Powerful And Compelling Clinical Data And Then Seeking Partners To Complete The Clinical Development And Commercialization Process P2D Currently Has A Pipeline Of Nine Drug Candidates To Treat Adhdobesity And Diabetesalzheimer S Diseasetraumatic Brain Injury And Copd
No conferences found for this company.
| Company Name | P2d Bioscience Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
